Comment on fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis

Allen Pai^{1

2}, Yung-Heng Lee^{3

4

5}, Meng-Yu Ko^{6

7}, Po-Ku Chen^{8

9}

Affiliations

¹ New Drug, New Medical Device, New Medical Technology Clinical Trial Management Center, Chung Shan Medical University Hospital, Taichung, Taiwan.
² Department of Public Health, National Taiwan University, Taipei, Taiwan.
³ Department of Senior Services Industry Management, Minghsin University of Science and Technology, Hsinchu, Taiwan.
⁴ Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
⁵ Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.
⁶ Division of Gastroenterology and Hepatology, Changhua Christian Hospital, Changhua, Taiwan.
⁷ Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
⁸ Chung Shan Medical University Hospital, Chung Shan Medical University, Taichung, Taiwan.
⁹ Department of Integrated Chinese and Western Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.

PMID: 36239091
DOI: 10.1111/1756-185X.14460

Comment

Comment on fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis

Allen Pai et al. Int J Rheum Dis. 2023 Jan.

. 2023 Jan;26(1):172-174.

doi: 10.1111/1756-185X.14460. Epub 2022 Oct 14.

Authors

Allen Pai^{1

2}, Yung-Heng Lee^{3

4

5}, Meng-Yu Ko^{6

7}, Po-Ku Chen^{8

9}

Affiliations

¹ New Drug, New Medical Device, New Medical Technology Clinical Trial Management Center, Chung Shan Medical University Hospital, Taichung, Taiwan.
² Department of Public Health, National Taiwan University, Taipei, Taiwan.
³ Department of Senior Services Industry Management, Minghsin University of Science and Technology, Hsinchu, Taiwan.
⁴ Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
⁵ Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.
⁶ Division of Gastroenterology and Hepatology, Changhua Christian Hospital, Changhua, Taiwan.
⁷ Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
⁸ Chung Shan Medical University Hospital, Chung Shan Medical University, Taichung, Taiwan.
⁹ Department of Integrated Chinese and Western Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.

PMID: 36239091
DOI: 10.1111/1756-185X.14460

No abstract available

PubMed Disclaimer

Comment in

Answer to "comment on fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis".
Campos JF, Resende GG, Ferrari MLA. Campos JF, et al. Int J Rheum Dis. 2023 Jan;26(1):175-176. doi: 10.1111/1756-185X.14458. Epub 2022 Oct 14. Int J Rheum Dis. 2023. PMID: 36239090 No abstract available.

Comment on

Fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis.
Campos JF, Resende GG, Barbosa AJA, de Carvalho SC, Lage JA, Cunha PFS, de Souza SCS, Ferrari MLA. Campos JF, et al. Int J Rheum Dis. 2022 Sep;25(9):1078-1086. doi: 10.1111/1756-185X.14388. Epub 2022 Jul 18. Int J Rheum Dis. 2022. PMID: 35855677

References

REFERENCES

1. Campos JF, Resende GG, Barbosa AJA, et al. Fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis. Int J Rheum Dis. 2022;25:1078-1086. doi:10.1111/1756-185X.14388
1. Wang S, Tsou HK, Chiou JY, Wang YH, Zhang Z, Wei JC. Increased risk of inflammatory bowel disease among patients with ankylosing spondylitis: a 13-year population-based cohort study. Front Immunol. 2020;11:578732. doi:10.3389/fimmu.2020.578732
1. Feng HY, Chan CH, Chu YC, Qu XM, Wang YH, Wei JC. Patients with ankylosing spondylitis have high risk of irritable bowel syndrome: a long-term nationwide population-based cohort study. Postgrad Med. 2022;134(3):290-296. doi:10.1080/00325481.2022.2041338
1. Chen HY, Wang SI, Chang R, Wei JC. Letter: association between COVID-19 and inflammatory bowel disease. Aliment Pharmacol Ther. 2022;55(9):1226-1227. doi:10.1111/apt.16814
1. Massironi S, Fanetti I, Viganò C, et al. Systematic review-pancreatic involvement in inflammatory bowel disease. Aliment Pharmacol Ther. 2022;55(12):1478-1491. doi:10.1111/apt.16949

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Comment on fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis

Affiliations

Comment on fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis

Authors

Affiliations

Comment in

Comment on

References

REFERENCES

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources